Lindis Biotech GmbH
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Investigation of Safety and Tolerability of Catumaxomab in Patients With NMIBC (NCT04819399) | Lindis Biotech GmbH | 2020-07-07 |
Track Lindis Biotech GmbH automatically
Every clearance here is in the API, with alerts when new ones post.